| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Menopause | 38 | 2020 | 109 | 8.270 |
Why?
|
| Breast Neoplasms | 34 | 2020 | 762 | 7.680 |
Why?
|
| Quality of Life | 37 | 2020 | 964 | 7.170 |
Why?
|
| Hot Flashes | 22 | 2020 | 49 | 4.840 |
Why?
|
| Women's Health | 28 | 2021 | 230 | 3.950 |
Why?
|
| Survivors | 12 | 2018 | 173 | 2.830 |
Why?
|
| Acupuncture Therapy | 6 | 2019 | 19 | 2.420 |
Why?
|
| Adaptation, Psychological | 8 | 2017 | 131 | 2.340 |
Why?
|
| Middle Aged | 85 | 2021 | 11851 | 2.200 |
Why?
|
| Depression | 17 | 2018 | 420 | 1.990 |
Why?
|
| Female | 97 | 2021 | 19945 | 1.930 |
Why?
|
| Perimenopause | 8 | 2021 | 14 | 1.930 |
Why?
|
| Health Status | 8 | 2019 | 355 | 1.910 |
Why?
|
| Longitudinal Studies | 30 | 2020 | 757 | 1.730 |
Why?
|
| Sexual Behavior | 6 | 2018 | 130 | 1.690 |
Why?
|
| Yoga | 5 | 2019 | 51 | 1.590 |
Why?
|
| Humans | 102 | 2021 | 32282 | 1.540 |
Why?
|
| Adult | 61 | 2021 | 9259 | 1.520 |
Why?
|
| Ethnic Groups | 12 | 2019 | 450 | 1.480 |
Why?
|
| Vasomotor System | 10 | 2021 | 25 | 1.450 |
Why?
|
| Sexuality | 4 | 2017 | 14 | 1.270 |
Why?
|
| Sweating | 10 | 2020 | 16 | 1.230 |
Why?
|
| Exercise | 4 | 2020 | 603 | 1.040 |
Why?
|
| Aging | 9 | 2020 | 942 | 1.030 |
Why?
|
| Premenopause | 7 | 2018 | 53 | 1.020 |
Why?
|
| Stress, Psychological | 8 | 2018 | 217 | 0.950 |
Why?
|
| Sickness Impact Profile | 4 | 2014 | 39 | 0.950 |
Why?
|
| Body Mass Index | 8 | 2020 | 863 | 0.930 |
Why?
|
| Social Support | 7 | 2017 | 180 | 0.900 |
Why?
|
| Aged | 29 | 2020 | 10263 | 0.900 |
Why?
|
| Postmenopause | 8 | 2017 | 424 | 0.890 |
Why?
|
| Attitude to Health | 6 | 2009 | 138 | 0.870 |
Why?
|
| United States | 33 | 2021 | 4072 | 0.790 |
Why?
|
| Psychometrics | 4 | 2015 | 137 | 0.770 |
Why?
|
| Cross-Sectional Studies | 16 | 2020 | 1479 | 0.760 |
Why?
|
| Spirituality | 3 | 2018 | 38 | 0.720 |
Why?
|
| Anxiety | 9 | 2018 | 190 | 0.700 |
Why?
|
| Multivariate Analysis | 11 | 2018 | 651 | 0.670 |
Why?
|
| African Americans | 7 | 2017 | 1335 | 0.660 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2018 | 19 | 0.650 |
Why?
|
| Colorectal Neoplasms | 3 | 2020 | 219 | 0.640 |
Why?
|
| Risk Factors | 19 | 2020 | 3934 | 0.600 |
Why?
|
| Logistic Models | 11 | 2020 | 743 | 0.590 |
Why?
|
| Age Factors | 11 | 2020 | 1179 | 0.580 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 231 | 0.570 |
Why?
|
| Patient Participation | 2 | 2012 | 90 | 0.570 |
Why?
|
| Time Factors | 11 | 2019 | 2205 | 0.560 |
Why?
|
| Neoplasms | 4 | 2019 | 754 | 0.550 |
Why?
|
| Mental Health | 5 | 2020 | 111 | 0.540 |
Why?
|
| Cohort Studies | 11 | 2020 | 1840 | 0.540 |
Why?
|
| Socioeconomic Factors | 10 | 2018 | 388 | 0.530 |
Why?
|
| Mammaplasty | 1 | 2017 | 26 | 0.530 |
Why?
|
| Breast | 1 | 2018 | 63 | 0.520 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2017 | 12 | 0.510 |
Why?
|
| Educational Status | 7 | 2019 | 167 | 0.500 |
Why?
|
| Waist Circumference | 1 | 2017 | 91 | 0.500 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 84 | 0.490 |
Why?
|
| Health Behavior | 2 | 2017 | 211 | 0.480 |
Why?
|
| Smoking | 6 | 2019 | 505 | 0.480 |
Why?
|
| Mastectomy | 4 | 2017 | 59 | 0.480 |
Why?
|
| Estradiol | 6 | 2021 | 139 | 0.480 |
Why?
|
| Prostatic Neoplasms | 3 | 2020 | 489 | 0.460 |
Why?
|
| Models, Theoretical | 1 | 2016 | 139 | 0.460 |
Why?
|
| Workplace | 1 | 2015 | 37 | 0.450 |
Why?
|
| Cross-Cultural Comparison | 5 | 2016 | 20 | 0.440 |
Why?
|
| Body Weight | 1 | 2017 | 323 | 0.440 |
Why?
|
| Libido | 3 | 2015 | 5 | 0.430 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 3900 | 0.390 |
Why?
|
| Decision Making | 3 | 2012 | 189 | 0.390 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 2240 | 0.380 |
Why?
|
| Ovariectomy | 2 | 2017 | 202 | 0.370 |
Why?
|
| Women | 2 | 2009 | 12 | 0.360 |
Why?
|
| European Continental Ancestry Group | 10 | 2017 | 1076 | 0.350 |
Why?
|
| Health Surveys | 7 | 2009 | 175 | 0.340 |
Why?
|
| Prospective Studies | 8 | 2020 | 2316 | 0.340 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2019 | 216 | 0.340 |
Why?
|
| Hispanic Americans | 8 | 2017 | 772 | 0.330 |
Why?
|
| Asian Americans | 6 | 2017 | 92 | 0.330 |
Why?
|
| Health Status Indicators | 2 | 2015 | 69 | 0.320 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 1158 | 0.310 |
Why?
|
| Testosterone | 4 | 2018 | 48 | 0.300 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2021 | 30 | 0.300 |
Why?
|
| Markov Chains | 2 | 2020 | 31 | 0.290 |
Why?
|
| Hypnosis | 1 | 2008 | 4 | 0.290 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 40 | 0.280 |
Why?
|
| Continental Population Groups | 4 | 2019 | 228 | 0.280 |
Why?
|
| Dyspareunia | 3 | 2018 | 6 | 0.280 |
Why?
|
| Prevalence | 8 | 2018 | 955 | 0.270 |
Why?
|
| Pain | 3 | 2018 | 304 | 0.260 |
Why?
|
| Treatment Outcome | 5 | 2017 | 3416 | 0.260 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2006 | 8 | 0.240 |
Why?
|
| Life Change Events | 3 | 2013 | 20 | 0.240 |
Why?
|
| Mental Disorders | 1 | 2007 | 115 | 0.240 |
Why?
|
| Vulvar Diseases | 1 | 2006 | 5 | 0.240 |
Why?
|
| Informed Consent | 1 | 2006 | 44 | 0.230 |
Why?
|
| Pelvic Pain | 1 | 2006 | 19 | 0.230 |
Why?
|
| Pilot Projects | 3 | 2016 | 553 | 0.220 |
Why?
|
| Menopause, Premature | 3 | 2018 | 11 | 0.220 |
Why?
|
| Cognition | 5 | 2019 | 547 | 0.220 |
Why?
|
| Mammography | 1 | 2004 | 41 | 0.210 |
Why?
|
| Emotions | 2 | 2018 | 54 | 0.210 |
Why?
|
| Cultural Diversity | 1 | 2004 | 17 | 0.210 |
Why?
|
| Video Recording | 1 | 2004 | 61 | 0.210 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 312 | 0.210 |
Why?
|
| Self Concept | 1 | 2004 | 45 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2008 | 158 | 0.200 |
Why?
|
| Interpersonal Relations | 3 | 2013 | 56 | 0.200 |
Why?
|
| Male | 11 | 2020 | 19441 | 0.200 |
Why?
|
| Marital Status | 4 | 2018 | 21 | 0.200 |
Why?
|
| Menarche | 2 | 2020 | 4 | 0.190 |
Why?
|
| Cognition Disorders | 2 | 2019 | 349 | 0.190 |
Why?
|
| Masturbation | 2 | 2015 | 2 | 0.190 |
Why?
|
| Japan | 4 | 2017 | 19 | 0.190 |
Why?
|
| China | 4 | 2017 | 56 | 0.180 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 245 | 0.180 |
Why?
|
| Affect | 3 | 2021 | 70 | 0.180 |
Why?
|
| Life Style | 7 | 2016 | 393 | 0.180 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 853 | 0.180 |
Why?
|
| Registries | 2 | 2013 | 294 | 0.170 |
Why?
|
| Pregnanediol | 1 | 2021 | 1 | 0.170 |
Why?
|
| Luteinizing Hormone | 1 | 2021 | 16 | 0.170 |
Why?
|
| Climacteric | 3 | 2007 | 6 | 0.170 |
Why?
|
| Role | 2 | 2012 | 5 | 0.170 |
Why?
|
| Dehydroepiandrosterone Sulfate | 3 | 2018 | 8 | 0.170 |
Why?
|
| Progesterone | 1 | 2021 | 78 | 0.170 |
Why?
|
| Analysis of Variance | 2 | 2018 | 471 | 0.170 |
Why?
|
| Chronic Disease | 3 | 2016 | 413 | 0.160 |
Why?
|
| Prognosis | 2 | 2020 | 1534 | 0.160 |
Why?
|
| Vaginal Diseases | 2 | 2018 | 7 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2020 | 854 | 0.160 |
Why?
|
| Activities of Daily Living | 2 | 2013 | 245 | 0.160 |
Why?
|
| Hysterectomy | 2 | 2018 | 52 | 0.160 |
Why?
|
| Karnofsky Performance Status | 1 | 2020 | 12 | 0.160 |
Why?
|
| Biomedical Research | 2 | 2013 | 178 | 0.160 |
Why?
|
| Psychology | 2 | 2013 | 25 | 0.160 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2020 | 51 | 0.160 |
Why?
|
| Incidence | 5 | 2020 | 1241 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 83 | 0.160 |
Why?
|
| Peripheral Nerves | 1 | 2020 | 60 | 0.160 |
Why?
|
| Patient Compliance | 2 | 2016 | 205 | 0.150 |
Why?
|
| Australia | 4 | 2020 | 35 | 0.150 |
Why?
|
| Accidental Falls | 1 | 2020 | 104 | 0.150 |
Why?
|
| Needs Assessment | 1 | 2020 | 78 | 0.150 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 83 | 0.150 |
Why?
|
| Regression Analysis | 2 | 2012 | 273 | 0.150 |
Why?
|
| Cranial Irradiation | 1 | 2019 | 94 | 0.150 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 595 | 0.140 |
Why?
|
| Ovarian Diseases | 1 | 2018 | 9 | 0.140 |
Why?
|
| Premenstrual Syndrome | 1 | 2018 | 3 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 541 | 0.140 |
Why?
|
| Demography | 1 | 2018 | 101 | 0.140 |
Why?
|
| Pain Measurement | 3 | 2016 | 341 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 2018 | 68 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2020 | 456 | 0.130 |
Why?
|
| Sleep | 2 | 2016 | 84 | 0.130 |
Why?
|
| Beauty | 1 | 2017 | 5 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2018 | 211 | 0.120 |
Why?
|
| Proportional Hazards Models | 4 | 2020 | 773 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 591 | 0.120 |
Why?
|
| Hormone Replacement Therapy | 3 | 2018 | 94 | 0.120 |
Why?
|
| Obesity | 2 | 2020 | 1111 | 0.120 |
Why?
|
| Models, Biological | 1 | 2018 | 408 | 0.120 |
Why?
|
| Probability | 2 | 2007 | 155 | 0.120 |
Why?
|
| Social Perception | 1 | 2015 | 22 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2015 | 72 | 0.110 |
Why?
|
| Menstruation | 1 | 2015 | 5 | 0.110 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2016 | 47 | 0.110 |
Why?
|
| Hyperhidrosis | 2 | 2020 | 6 | 0.110 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2015 | 15 | 0.110 |
Why?
|
| Cytokines | 1 | 2016 | 237 | 0.110 |
Why?
|
| Linear Models | 2 | 2013 | 425 | 0.110 |
Why?
|
| Data Collection | 2 | 2006 | 171 | 0.110 |
Why?
|
| Neoplasm Staging | 2 | 2007 | 461 | 0.110 |
Why?
|
| Social Adjustment | 1 | 2014 | 11 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 555 | 0.110 |
Why?
|
| Depressive Disorder | 2 | 2012 | 69 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 255 | 0.110 |
Why?
|
| Asian Continental Ancestry Group | 3 | 2016 | 101 | 0.100 |
Why?
|
| Behavioral Sciences | 1 | 2013 | 1 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 443 | 0.100 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 199 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2013 | 52 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 390 | 0.100 |
Why?
|
| Leukemia | 1 | 2013 | 38 | 0.100 |
Why?
|
| Lymphoma | 1 | 2013 | 37 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 69 | 0.090 |
Why?
|
| Anthracyclines | 1 | 2013 | 52 | 0.090 |
Why?
|
| Syndrome | 2 | 2018 | 66 | 0.090 |
Why?
|
| Patient Preference | 1 | 2012 | 48 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2013 | 368 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2019 | 1425 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2012 | 184 | 0.090 |
Why?
|
| Age of Onset | 2 | 2018 | 90 | 0.090 |
Why?
|
| Reward | 1 | 2012 | 64 | 0.090 |
Why?
|
| African Continental Ancestry Group | 3 | 2016 | 338 | 0.090 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 327 | 0.080 |
Why?
|
| Population Surveillance | 2 | 2008 | 120 | 0.080 |
Why?
|
| Endocrine Glands | 1 | 2010 | 2 | 0.080 |
Why?
|
| Computational Biology | 1 | 2010 | 99 | 0.080 |
Why?
|
| Public Health | 1 | 2010 | 91 | 0.070 |
Why?
|
| Mental Processes | 1 | 2009 | 15 | 0.070 |
Why?
|
| Social Behavior | 1 | 2009 | 69 | 0.070 |
Why?
|
| Young Adult | 2 | 2013 | 2649 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 466 | 0.070 |
Why?
|
| Placebo Effect | 1 | 2008 | 18 | 0.070 |
Why?
|
| Research Design | 2 | 2010 | 314 | 0.070 |
Why?
|
| North Carolina | 1 | 2012 | 1300 | 0.070 |
Why?
|
| Estrogens | 1 | 2010 | 194 | 0.070 |
Why?
|
| Affective Symptoms | 1 | 2008 | 15 | 0.070 |
Why?
|
| Europe | 2 | 2018 | 82 | 0.070 |
Why?
|
| Palliative Care | 1 | 2008 | 51 | 0.070 |
Why?
|
| Risk | 2 | 2020 | 305 | 0.070 |
Why?
|
| Survival Rate | 2 | 2007 | 893 | 0.070 |
Why?
|
| New Hampshire | 1 | 2006 | 4 | 0.060 |
Why?
|
| Boston | 1 | 2006 | 16 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2012 | 3626 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 53 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 95 | 0.060 |
Why?
|
| Travel | 1 | 2006 | 14 | 0.060 |
Why?
|
| New Jersey | 1 | 2006 | 9 | 0.060 |
Why?
|
| Happiness | 1 | 2005 | 3 | 0.060 |
Why?
|
| Contraception | 1 | 2005 | 11 | 0.060 |
Why?
|
| Shock, Cardiogenic | 1 | 2005 | 16 | 0.060 |
Why?
|
| Perception | 1 | 2006 | 99 | 0.060 |
Why?
|
| Myocardial Revascularization | 1 | 2005 | 34 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 545 | 0.060 |
Why?
|
| Florida | 1 | 2005 | 42 | 0.060 |
Why?
|
| Vagina | 1 | 2005 | 61 | 0.060 |
Why?
|
| Pamphlets | 1 | 2004 | 5 | 0.050 |
Why?
|
| Patient Selection | 1 | 2006 | 272 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 179 | 0.050 |
Why?
|
| Age Distribution | 1 | 2004 | 194 | 0.050 |
Why?
|
| Sex Factors | 1 | 2006 | 655 | 0.050 |
Why?
|
| Adolescent | 2 | 2016 | 3519 | 0.050 |
Why?
|
| Stroke | 2 | 2020 | 691 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 381 | 0.050 |
Why?
|
| Education | 1 | 2003 | 31 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 287 | 0.050 |
Why?
|
| Comorbidity | 2 | 2018 | 565 | 0.050 |
Why?
|
| Child | 2 | 2020 | 2435 | 0.050 |
Why?
|
| Mass Screening | 1 | 2004 | 256 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2013 | 20 | 0.050 |
Why?
|
| Angina Pectoris | 1 | 2020 | 20 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 757 | 0.040 |
Why?
|
| Appalachian Region | 1 | 2020 | 23 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 37 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 285 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2019 | 107 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 76 | 0.040 |
Why?
|
| Coitus | 1 | 2018 | 2 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 148 | 0.040 |
Why?
|
| Rural Population | 1 | 2020 | 216 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2019 | 226 | 0.030 |
Why?
|
| Thinness | 1 | 2018 | 32 | 0.030 |
Why?
|
| Memory | 2 | 2010 | 202 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 116 | 0.030 |
Why?
|
| Middle East | 1 | 2016 | 5 | 0.030 |
Why?
|
| Latin America | 1 | 2016 | 6 | 0.030 |
Why?
|
| Overweight | 1 | 2018 | 252 | 0.030 |
Why?
|
| Patient Care Management | 1 | 2016 | 19 | 0.030 |
Why?
|
| Meditation | 1 | 2016 | 27 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 76 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2016 | 29 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 120 | 0.030 |
Why?
|
| Checklist | 1 | 2015 | 39 | 0.030 |
Why?
|
| Computer Security | 1 | 2013 | 8 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2013 | 26 | 0.020 |
Why?
|
| Medical Informatics | 1 | 2013 | 26 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2013 | 26 | 0.020 |
Why?
|
| Irritable Mood | 1 | 2013 | 5 | 0.020 |
Why?
|
| Troponin I | 1 | 2013 | 20 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 2013 | 6 | 0.020 |
Why?
|
| Fear | 1 | 2013 | 42 | 0.020 |
Why?
|
| International Cooperation | 1 | 2013 | 31 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 86 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 965 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2013 | 39 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2012 | 59 | 0.020 |
Why?
|
| Health Policy | 1 | 2013 | 89 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 202 | 0.020 |
Why?
|
| Mothers | 1 | 2012 | 74 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 264 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 883 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 22 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2010 | 31 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2010 | 13 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2013 | 417 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2010 | 171 | 0.020 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2008 | 1 | 0.020 |
Why?
|
| Selection Bias | 1 | 2008 | 13 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 1224 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 556 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2007 | 15 | 0.020 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2005 | 7 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2005 | 37 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2005 | 63 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 100 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 477 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2005 | 239 | 0.010 |
Why?
|